Babyshkina, N., Zavyalova, M., Tarabanovskaya, N., Dronova, T., Krakhmal, N., Slonimskaya, E., . . . Cherdyntseva, N. (2017). Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy. Molecular and cellular biochemistry, 444(1), . https://doi.org/10.1007/s11010-017-3244-1
Chicago Style (17th ed.) CitationBabyshkina, Nataliya, Marina Zavyalova, Natalia Tarabanovskaya, Tatyana Dronova, Nadejda Krakhmal, Elena Slonimskaya, Julia Kzhyshkowska, Evgeny Choynzonov, and Nadejda Cherdyntseva. "Predictive Value of Vascular Endothelial Growth Factor Receptor Type 2 in Triple-negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy." Molecular and Cellular Biochemistry 444, no. 1 (2017). https://doi.org/10.1007/s11010-017-3244-1.
MLA (9th ed.) CitationBabyshkina, Nataliya, et al. "Predictive Value of Vascular Endothelial Growth Factor Receptor Type 2 in Triple-negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy." Molecular and Cellular Biochemistry, vol. 444, no. 1, 2017, https://doi.org/10.1007/s11010-017-3244-1.